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ABSTRACT
Flavonoids, natural phenolic compounds, are known as agents with strong antioxidant properties. In many diseases associated with 
oxidative/nitrosative stress and aging they provide multiple biological health benefits. Ca2+-ATPases belong to the main calcium 
regulating proteins involved in the balance of calcium homeostasis, which is impaired in oxidative/nitrosative stress and related 
diseases or aging. The mechanisms of Ca2+-ATPases dysfunction are discussed, focusing on cystein oxidation and tyrosine nitration. 
Flavonoids act not only as antioxidants but are also able to bind directly to Ca2+-ATPases, thus changing their conformation, which 
results in modulation of enzyme activity. 
Dysfunction of Ca2+-ATPases is summarized with respect to their posttranslational and conformational changes in diseases related 
to oxidative/nitrosative stress and aging. Ca2+-ATPases are discussed as a therapeutic tool and the possible role of flavonoids in this 
process is suggested. 
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The importance of Ca2+-ATPases, their impairment 
and impact as a possible therapeutic tool in diseases 
related to oxidative/nitrosative stress has not yet been 
summarized. This review deals with the modulation of 
Ca2+-ATPases by oxidative/nitrosative stress in vitro and 
in diseases and with their potential therapeutic effect. 
Flavonoids are phenolic compounds known as char-
acteristic red, blue and purple anthocyanin pigments of 
plant tissues (Winkel-Shirley et al., 2001). Flavonoids 
occur in food either as free monomers (quercetin, cat-
echin) or oligomers (procyanidins), or they are bound to 
saccharides as glycosides. Consumption of flavonoid-rich 
food is associated with a lower incidence of coronary 
heart disease, myocardial infarction, cancer, neurode-
generative psychic diseases, and other chronic diseases. In 
the pathology of these diseases, oxidative stress has been 
assumed to play a role and flavonoids have been suggested 
to exert health benefits through antioxidant mechanisms. 
In addition to their antioxidant properties, flavonoids have 
been reported to exhibit other multiple biological effects, 
antiviral, antibacterial, anti-inflammatory, vasodilatory, 
anticancer, anti-ischemic, etc. (Procházková et al., 2011). 
An important aim of the present review is to elucidate 
another mechanism by which flavonoids may exert health 
benefits, i.e. the modulation of calcium homeostasis and 
cell signaling via Ca2+-ATPase.
Introduction
Free oxygen and nitrogen reactive species (ROS, RNS) are 
participating in aging and age related diseases. The search 
for mechanisms of oxidative/nitrosative injury involved 
in diseases and aging is important for finding new thera-
peutic approaches. Impairment of calcium homeostasis 
is a consequence of oxidative/nitrosative stress. In recent 
years, many results were published showing that dysfunc-
tion of Ca2+-ATPases, the main calcium level regulating 
proteins, is included in the above mentioned conditions. 
In addition, modulation of Ca2+-ATPases by antioxidants 
may be a therapeutic tool for improvement of complica-
tions associated with human diseases and their experi-
mental animal models. Flavonoids, in addition to their 
antioxidant properties exert beneficial effects based on 
their ability to bind to Ca2+-ATPases and thus to change 
their activity.
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Antioxidant properties and structure
Both the configuration and the total number of hydroxyl 
groups substancialy influence the mechanism of anti-
oxidant activity (Heim et al., 2002). The basic structure 
of flavonoids is depicted in Figure 1. The B ring hydroxyl 
configuration is the most significant determinant of ROS 
scavenging (Burda & Oleszek, 2001), whereas substitution 
of the rings A and C has little influence on superoxide 
anion radical scavenging (Taubert et al., 2003; Amic et al., 
2007). The in vitro antioxidant activity could be increased 
by polymerization of flavonoid monomers (proanthocy-
anidins known also as condensed tannins). The polymers 
of catechins are excellent in vitro antioxidants due to 
the high number of hydroxyl groups. The glycosylation 
of flavonoids reduces their in vitro antioxidant activity, 
compared with corresponding aglycones (Procházková et 
al., 2011). Glycosylation of the 3-OH group has namely 
strong suppresive effect on their antioxidant activity 
(Rice-Evans et al.,1996).
Structural features of flavonoids required for efficient 
radical scavenging are i) an ortho-dihydroxy (catechol)
structure in the B ring for electron delocalization, ii) 
2,3-double bond in conjugation with a 4-oxo function in 
the C ring providing electron delocalization from the B 
ring, iii) hydroxyl groups at positions 3 and 5 providing 
hydrogen bonding to the oxo group (Croft 2006) (Figure 2).
Ability to activate or inhibit enzymes
The ability to interact with various antioxidant enzymes 
belongs also to important mechanisms of flavonoids in 
preventing injury caused by free radicals. Protective 
effects of quercetin and catechin against hydrogen perox-
ide toxicity in cultured rat hepatocytes BL-9 were related 
to the activation of glutathione peroxidase (GPx) (Nagata 
et al., 1999). Activation of survival signaling proteins (pro-
tein kinase B and extracellular regulated kinases) as well 
as increase of GPx and glutathione reductase (GR) caused 
by cocoa flavonoids was observed in human hepatocytes 
(Martin et al., 2010). Luteonin induced human lung car-
cinoma cell apoptosis was accompanied by activation of 
antioxidant enzymes such as superoxide dismutase (SOD) 
and catalase (CAT) (Leung et al., 2006).
Flavonoids inhibit the enzymes responsible for super-
oxide production, e.g. xanthine oxidase and protein kinase 
C. Flavonoids have been shown to inhibit cyclooxygenase, 
lipoxygenase, microsomal succinoxidase and NADH 
oxidase. Flavonoids were found to exert an inhibitory 
effect on the expression of inducible nitric oxide syn-
thase (NOS), yet they did not inhibit its activity. Several 
flavonoids, including quercetin, induce a reduction of 
ischemia-reperfusion injury by interfering with inducible 
NOS activity (Procházková et al., 2011).
Ability to modulate sarco/endoplasmic 
reticulum Ca2+-ATPase (SERCA)
Physiological importance of SERCA
SERCA is an intracellular membrane-bound enzyme 
that utilizes the free energy of ATP to transport Ca2+ 
against a concentration gradient. The physiological role 
of SERCA is to sequester cytosolic Ca2+ into membrane-
bound intracellular compartments. SERCA-mediated 
Ca2+ uptake into stores plays a key role in maintenance of 
intracellular free Ca2+ levels within a physiological range. 
In addition, during contractions caused by elevated levels 
of intracellular Ca2+, accelerated sequestration of Ca2+ 
by SERCA mediates smooth, cardiac, and skeletal muscle 
relaxation. In non-contractile cells, such as proliferating 
smooth muscle cells or endothelium, SERCA regulates 
many cellular processes, including cell growth, apopto-
sis and migration. Ca2+-ATPase dysfunction has been 
detected in experimental and human pathology (Tong et 
al., 2010; Inesi et al., 2005.)
Mechanisms of SERCA regulation
The mechanisms of intracellular calcium regulation by 
SERCA, involved in vascular relaxation, in cardiac and 
muscle relaxation, as well as in growth and differen-
tiation, may include peroxinitrite (generated from nitric 
oxide and superoxide), which causes glutathione (GSH) to 
bind to SERCA cysteine thiols (Cohen et al., 2006). GSH, 
when oxidized, is rapidly reduced and/or resynthetized to 
protect proteins from oxidation. With RNS GSH forms, 
S-nitroso glutathione (GSNO), sulfenic acid (GSOH), and 
GSH thiyl radicals (GS.), which can react with nearby pro-
tein thiols. Protein thiolate anions (R-S–) are predisposed 
to react with these species. Chemical adducts of protein 
thiols generated in the presence of RNS include Pr-SNO 
(generated by S-nitrosylation), Pr-SSG (generated by 
glutathiolation) and oxidized thiols (Pr-SOH), (Pr-SO2H), 
(PrSO3H), as well as intra- and inter-protein dithiols. All 
modifications, except those of sulfinic acid (Pr-SO2H) and 
sulfonic acid (PrSO3H), are reversible under physiologic 
conditions, enabling them to participate in cell signaling. 
Another peroxynitrite product is nitrotyrosine. In 
SERCA2 in the aging heart and skeletal muscle nitration 
of vicinal tyrosines, Tyr 294 and Tyr295 was demonstrated 
on the luminal side of the membrane-spanning helix M4, 
correlating with partial inhibition of Ca-ATPase activ-
ity. This is suggesting a possible regulatory function in 
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down-regulating mitochondrial energy production and 
the associated decrease in generation of reactive oxygen/
nitrogen species (Bigelow, 2007). Nitrotyrosine is gener-
ated from nitric-oxide-derived oxidants, mainly of the 
CO2 adduct of peroxynitrite (ONOO-) or of NO2 (Pacher 
et al., 2007). Peroxynitrite reacts rapidly with such 
nucleophiles as protein thiols and transition metal cen-
ters, and the physiologically abundant CO2, which occurs 
in millimolar concentrations in cells. The CO2 adduct 
nitrosoperoxycarbonate (ONOOCO2) rapidly homolyzes 
to •CO–
3 (carbonate radical) and .NO2 (nitrogen dioxide) 
to undergo a radical mechanism of tyrosine nitration. 
This involves hydrogen atom abstraction from the 3-posi-
tion of tyrosine to form the tyrosyl radical that rapidly 
combines with .NO2 forming 3-nitrotyrosine. Protein 
nitration may also be formed by generation of •NO2 by 
heme peroxidases, such as myeloperoxidase and eosino-
phil peroxidase, in the presence of hydrogen peroxide.
Low concentrations of peroxynitrite induce 
S-glutathiolation of SERCA2 in vivo, whereas higher 
concentratioins of peroxynitrite result in irreversible 
modification of Cys674 to cystein sulfonic acid (Cys-SO3H) 
and accompanying nitrotyrosine modification (Cohen et 
al., 2006).
SERCA isomers and structure
Three genes for SERCA have been identified (SERCA1, 
SERCA2, and SERCA3), and different SERCA isoforms 
are expressed in tissue-specific and developmentally 
regulated patterns (Dremina et al., 2007). The fast-twitch 
m u s c l e  i s o f o r m  S E R C A 1  i s  r e s t r i c t e d  t o  f a s t - t w i c h  
skeletal muscle, while SERCA2a is expressed in cardiac 
and slow-twitch skeletal muscle. The isoforms SERCA2b 
and SERCA3a-3f are present in a large variety of tissues, 
including nonmuscle tissues.
SERCA belongs to the "P" family of cation transport 
ATPases, all of them forming phosphorylated enzyme 
intermediates by covalent interaction of the ATP terminal 
phosphate with an aspartyl residue at the catalytic site 
(Inesi et al., 2005). ATPase includes a membrane-bound 
region connected through a stalk to an extramembranous 
(i.e. cytosolic ) headpiece. Ca-binding sites are located 
within the membrane-bound region, the ATP binding 
(nucleotide binding) site is situated in the cytosolic region 
of SERCA (Tupling et al., 2001).
SERCA, oxidation and natural plant products
SERCA pumps play a central role in maintaining low 
levels of free cytosolic calcium within cells. This Ca2+ 
pump is inhibited by a wide spectrum of hydrophobic 
molecules, a number of which are plant-derived natural 
products, such as thapsigargin (Wictome et al.,1992), 
curcumin (Bilmen et al., 2001; Dyer et al., 2002), and the 
flavonoid quercetin (Shoshan et al., 1981). Flavonoids 
are able to bind to nucleotide binding sites, thus chang-
ing SERCA activity. Therefore one possible mechanism 
by which apoptosis is initiated by flavonoids is via Ca2+ 
pump inhibition leading to elevation of cytosolic [Ca2+], 
initiating Ca2+-dependent mitochondrial-mediated cell 
death (Ogunbayo et al., 2008).
Natural plant extracts with antioxidant properties and 
prevention against pathological reduction of the Ca-pump 
may offer dual protection against some cardiovascular, 
skeletal muscle and inflammatory diseases. Recent find-
ings showed that the inhibitory effect of HOCl, which 
reduced SR Ca2+-ATPase activity at least partially by 
structural changes, was prevented by standardized 
flavonoid extract from leaves of Ginkgo biloba (EGb761) 
(Štrosová et al., 2005). It is known that flavonoids are able 
to bind to proteins, thus changing their structure and 
function (Rohdewald, 2002).
The standardized extracts of plant flavonoids, EGb761 
and pycnogenol (Pyc) prevented sulfhydryl (SH) group 
oxidation and protein carbonyl (PCO) formation. Pyc in 
addition prevented thiobarbituric acid reactive species 
(TBARS) formation in SR oxidized by the Fenton system. 
The lower antioxidant effect of EGb761 compared with 
Pyc may be associated with the fact that OH-groups of 
compounds included in this extract and effective in 
scavenging free radicals are bound to glucose (Drieu, 
 
O
OH
HO
OH
O
OH
OH
AC
B
 
O HO
O
OH
OH
HO
A C
B
 
O HO
OH
OH
O
O
H H
O
AC
B
i) ii) iii)
Figure 2. i) Ortho-dihydroxy (catechol)structure in the B ring, ii) 2,3-double bond in conjugation with 4-oxo function, iii) hydroxyl groups 
at positions 3 and 5. 117
Also available online on PubMed Central
Interdisciplinary Toxicology. 2011; Vol. 4(3): 114–124
Copyright © 2011 Slovak Toxicology Society SETOX
1986). Mixtures of many compounds included in Pyc and 
EGb761 may have multiple and synergistic effects which 
could result in effective decrease of protein carbonyl 
formation. These extracts are also able to chelate Fe-ions 
and scavenge hydrogen peroxide and hydroxyl-radicals 
(Rohdewald, 2002; Sastre et al., 1998). In spite of these 
antioxidant and scavenging effects exerted by EGb761 
and Pyc, no protective effects on Ca2+-ATPase activity has 
been observed, on the contrary, an additional decreasing 
effect on the activity of this enzyme activity was observed. 
This effect may be caused by the interaction of flavonoids 
with free radicals derived from the Fenton system, induc-
ing injury by this secondary reaction. In addition, Pyc is 
able to inhibit Ca2+-ATPase activity also in the absence of 
oxidants. It is able to bind to proteins, alter their structure 
and thereby modulate the activity of key enzymes (Packer 
et al., 1999). The ability of Pyc to decrease Ca2+-ATPase 
activity under non-oxidized conditions was reported by 
Štrosova et al. (2006). Flavonoids included in the above 
mentioned standardized plant extracts may induce inhi-
bition or stimulation of key enzymes (Rohdewald, 2002). 
EGb761 or its individual flavonoid compounds are able 
to bind to protein. Their binding to the nucleotide (ATP-
binding) site of Ca2+-ATPase (Schroeter et al., 2000) as 
well as interaction with ion channels was reported (Ishige 
et al., 2001). We concluded that modulation of Ca-pump 
function by antioxidants depended on the mode of oxida-
tive injury (Voss et al., 2008). Both HOCl and radicals 
generated by the Fenton reaction are included in the pro-
cesses of inflammation and are able to induce structural 
changes in proteins resulting in a decrease of Ca-pump 
function. The protective effect of trolox and EGb761 on 
SERCA activity may be based on the interaction of spe-
cific (HOCl related) secondary oxidative products with 
antioxidants. On the other hand, the same antioxidants, 
in spite of the fact that they protected SH groups and 
prevented TBARS or carbonyl generation, were found 
to be ineffective in preventing SERCA activity decrease 
induced by the Fenton reaction associated with HO and 
ferryl-radicals generation.
We conclude that the ability to protect Ca2+-ATPase 
activity by antioxidants depends on the mode of oxidative 
injury. We further suggest that conformational alterations 
in cytosolic nucleotide (ATP)-binding or transmembrane 
Ca2+-binding regions of Ca2+-ATPase, which are now 
under investigation in our laboratory, may be also critical 
for protective effects of antioxidants.
Prooxidant properties of fl  avonoids
Under certain circumstances, flavonoids can act, as pro-
oxidants, promoting the oxidation of other compounds. 
The prooxidant activity is probably directly proportional 
to the total number of hydroxyl groups in the flavonoid 
molecule (Cao et al., 1997). Multiple hydroxyl groups, 
especially in the B-ring, significantly increased the pro-
duction of hydroxyl radicals in the Fenton reaction, while 
on the other hand, mono- and dihydroflavonoids failed to 
exert any prooxidant activity (Heim et al., 2002; Hanasaki 
et al., 1994). There is also evidence that the 2,3-double 
bond and 4-oxo arrangement of flavones may promote 
the formation of ROS induced by divalent copper in the 
presence of oxygen (Sun et al., 2010). Flavonoid prooxi-
dant properties seem to be concentration dependent. An 
example may be rat liver microsomes, where quercetin and 
myricetin powerfully inhibited iron-induced lipid peroxi-
dation at low micromolar concentrations (IC50 ≤ 1.5 μM). 
However at 100 μM concentration, hydroxyl radical for-
mation was greatly enhanced, up to eight-fold. We found 
that synthetically modulated derivatives of rutin exerted 
protective effects on ONOO–-mediated SERCA injury 
at low concentrations (5–50  μmol/l) and inhibitory at 
higher concentrations (100–250 μmol/l), (Viskupicova et 
al., 2009). Interestingly, the ability of rutin derivatives to 
inhibit SERCA activity in higher concentrations was not 
correlated with the prooxidant properties, probably due 
direct structural changes of SERCA by flavonoids.
Prooxidant or antioxidant properties of a particular 
flavonoid depend most expressively on its concentration. 
The furher could be associated with cell signaling by 
which flavonoids contribute to the co-ordination of cell 
functions.
Health benefi  ts of green tea to humans
Tea is one of the most widely consumed beverages in 
the world. Polyphenolic compounds in green tea have 
recently received increased attention as preventive agents 
that may provide health benefits to humans. Green tea 
polyphenols include epigallocatechin-3-gallate (EGCG), 
epigallocatechin (EGC), epicatechin-3-gallate (ECG), and 
epicatechin (EC). The chemical structure of catechins is 
shown in Figure 3. The health benefits attributed to tea 
might result at least partly from the inhibitory effect 
of EGCG on Na +,K+-ATPase and Ca2+-ATPase activity 
(Ochiai et al., 2009).
E G C G  i s  t h e  m o s t  a b u n d a n t  o f  t h e s e  c a t e c h i n s  
(Bettuzzi et al., 2006). It has been suggested to inhibit 
the activity of Na+,K+-ATPase in human erythrocyte 
ghosts (Rizvi & Zaid, 2005), P-type ATPases (gastric 
H+,K+-ATPase and sarcoplasmic reticulum Ca2+-ATPase). 
Daily intake of EGCG by drinking green tea may provide 
physiological benefits to humans via inhibition of Na+,K+-
ATPase. EGCG and ECG exert their inhibitory effect 
on the membrane-bound Na+,K+-ATPase allosterically 
through interaction with plasma membrane phospholipid. 
The two galloyl-type catechins (EGCg and ECg) showed 
a stronger inhibitory effect on Na+,K+-ATPase than the 
other two catechins lacking galloyl groups (EGC and EC). 
EGCg and ECG have a greater affinity for membrane 
phospholipid than EGC and EC (Kamihara et al., 2008).
Cancer chemoprotection by fl  avonoids
Some flavonoids have been reported to reach levels of 
several micromolars in human blood plasma (Erlund et 
al., 2002). Flavonoids are believed to be cancer chemo-
protective due to their ability to sensitize some cells 
into undergoing apoptosis, a process that has become 118
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misregulated in many cancers. One hypothesis is that 
flavonoids are able to initiate apoptosis, especially in can-
cer cells, via a Ca2+-dependent mitochondrial pathway 
(Ogunbayo et al., 2008). This pathway can be activated 
through an exaggerated elevation of cytosolic [Ca2+] 
and SERCA plays here an essential role by ameliorating 
such changes. Flavonoids (especially flavones) can inhibit 
the activity of Ca2+-ATPases isoforms SERCA1A and 
SERCA2B in the micromolar concentration range. Of the 
25 flavonoids tested, 3,6-dihydroxyflavone (IC50, 4.6 μM) 
and 3,30,40,5,7-pentahydroxyflavone (quercetin) (IC50, 
8.9  μM) were the most potent inhibitors. The polyhy-
droxylation of flavones is important for inhibition, with 
hydroxylation at position 3 (for SERCA1A) and position 
6 (for SERCA2B) being particularly relevant (Ogunbayo 
et al., 2008).
Natural flavonoid extract Pyc induced apoptosis in 
human mammary cancer cells, whereas normal mam-
mary cells were not affected (Rodewald, 2002). Pyc is 
able to inhibit SERCA (Štrosová et al., 2006; Voss et al., 
2008), which may be linked with its ability to induce 
apoptosis via an increase of tightly controlled cytosolic 
Ca2+. Similarly, other authors found an inhibiting effect of 
the anticancerogenic polyphenolic antioxidant curcumin 
against Ca2+-ATPase (Bilmen et al., 2001). Interestingly, 
the apoptosis of peripheral blood lymphocytes was on the 
contrary significantly reduced in patients with systemic 
lupus erythematosus treated with Pyc (Rodewald, 2002).
In recent years, research has shown that some fla-
vonoids can trigger apoptosis through the modulation 
of a number of key cellular signaling pathways that can 
cause increased cellular levels of caspases and decreased 
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levels of antiapoptotic factors such as Bcl-2-type proteins 
(Ramos, 2007; Selvendiran et al., 2006; Kuhar et al., 2006).
Green tea has been suggestive to be a rather effective 
cancer preventive beverage. Suganuma (2011) studied 
the effects of combining EGCG and anticancer drugs, 
focusing on inhibition of cell growth and induction of 
apoptosis. Synergistic enhancement of apoptosis, gene 
expression, and anticancer effects were found on using 
various combinations of EGCG and anticancer drugs, 
including the combination of (-)-epicatechin (EC) and 
curcumin (Suganuma et al., 2011).
Extracts of green tea and green tea polyphenols have 
exhibited inhibitory effects against the formation and 
development of tumors at different organ sites in animals 
(Yang & Wang, 2010). These include animal models for 
skin, lung, oral cavity, esophagus, stomach, intestine, 
colon, liver, pancreas, bladder, mammary gland, and pros-
tate cancers. In addition to suppressing cell proliferation, 
promoting apoptosis, and modulating signaling transduc-
tion, green tea polyphenols, especially EGCG, also inhibit 
cell invasion, angiogenesis, and metastasis (Yang & Wang, 
2010).
Flavonoids with inhibitory properties to Ca2+-ATPase 
activity may represent  agents with the ability to affect 
cellular processes known to be regulated by Ca2+, includ-
ing apoptosis, decreased synthesis of ATP and free radical 
formation.
Green tea fl  avonoids and brain dementia
Green and black tea drinking (rich in a class of flavonoids 
named catechins) may help protect the aging brain and 
reduce the incidence of dementia like Alzheimer´s disease 
(AD) and Parkinson´s disease (PD). Neuroprotective/
neuroregenerative effects of green tea catechins were 
found to act not only as antioxidant metal chelators but 
also as modulators of intracellular neuronal signaling and 
metabolism, of cell survival/death genes, and mitochon-
drial function. Thus, these dietary compounds are receiv-
ing significant attention as therapeutic multifunctional 
cytoprotective agents that simultaneously manipulate  
various brain targets (Mandel et al., 2011).
Cardioprotective eff  ects of fl  avonoids
Higher flavonoid intak e from fruits and vegetables is 
associated with decreased risk for the development of 
cardiovascular disease. The mechanisms explaining this 
observation remain unclear, but current evidence suggests 
that flavonoids may exert their effects through affecting 
cardiovascular risk factors. Flavonoids improve endothe-
lial function, inhibit low-density lipoprotein oxidation, 
decrease blood pressure and improve dyslipidemia in stud-
ies focused on cocoa, soy, and green and black tea. Some 
polyphenols in their purified form, including resveratrol, 
berberine and naringenin, exerted beneficial effects on 
dyslipidemia in humans and/or animals. In a mouse model 
of cardiovascular disease, naringenin treatment, through 
correction of dyslipidemia, hyperinsulinemia and obesity, 
attenuated atherosclerosis. Thus the beneficial effects of 
flavonoids on multiple risk factors may explain, in part, 
their observed beneficial effects on cardiovascular disease 
(Mulvihill & Huff, 2010).
Several authors studied the effects of green and 
black tea or their individual components on the risk of 
cardiovascular diseases. Regular consumption of black 
and green tea may reduce the risk of cardiovascular 
disease. The cardiovascular health benefits of drinking 
tea are thought to be largely due to flavonoids. Isolated 
flavonoids found in tea have also been consistently shown 
to inhibit the development of atherosclerosis in animal 
models (Hodgson & Croft, 2010). 
Molecular mechanisms of cardiovascular protection 
of green tea polyphenols, particularly EGCG, focusing 
on anti-oxidative and anti-inflammatory effects, were 
studied by Tipoe (2007). The most active component in 
green tea was found to be EGCG. Studies have shown 
that EGCG protects cellular damage by inhibiting DNA 
damage and oxidation of low density lipoproteins (LDL). 
One of the protective properties of EGCG is its ability to 
scavenge free radicals. EGCG was also able to reduce the 
inflammatory response associated with local tissue inju-
ries, such as hepatocellular necrosis in acute liver injury 
induced by carbon tetrachloride. The protective effect 
of EGCG is due to its ability to decrease lipid peroxida-
tion, oxidative stress and the production of nitric oxide 
(NO) radicals by inhibiting the expression of inducible 
nitric oxide synthase (iNOS). EGCG also ameliorates 
the overproduction of pro-inflammatory cytokines and 
mediators, reduces the activity of nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kappa 
B) and transcription factor AP-1 and the subsequent 
formation of peroxynitrite with NO and reactive oxygen 
species. Thus EGCG effectively mitigated cellular dam-
age by lowering the inflammatory reaction and reducing 
lipid peroxidation and NO-generated radicals leading to 
oxidative stress. Green tea is proposed to be a dietary 
supplement in the prevention of cardiovascular diseases, 
in which oxidative stress and proinflammation are the 
principal causes. 
Other studies concerning flavonoid benefits were 
focused on cardiac hypertrophy. Cardiac hypertrophy is a 
pathological response of the heart to chronic pressure or 
volume overload. Cardiac hypertrophy is a risk factor for 
ischemic heart disease, arrhythmia, and sudden death. It 
is therefore important to determine the mechanism of the 
development of cardiac hypertrophy and prevent or treat 
it. Chronic low level of cardiac myocyte apoptosis was 
proposed to be a causal component in the pathogenesis of 
heart failure (Sheng et al., 2007).
Many antioxidants have shown inhibitory effects on 
cardiac hypertrophy in vitro and in vivo induced by ROS 
(Sheng et al., 2007; Tsujimoto, 2005). EGCG and green tea 
were found to exert protective effects against cardiovas-
cular diseases (Chyu et al., 2004; Townsend et al., 2004). 
Green tea extracts and EGCG protected cardiomyocytes 
against ischemia/reperfusion-induced apoptotic cell 
death both in vivo and in vitro and effectively inhibited 120
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cardiac hypertrophy in mice and rats (Sheng et al., 2007; 
Li et al., 2006).
The inhibitory effects of EGCG on cardiac hypertro-
phy was tested by Sheng et al. (2007), and it was found 
that EGCG inhibited cardiac myocyte apopotosis and 
oxidative stress in pressure overload induced cardiac 
hypertrophy. EGCG also prevented cardiomyocyte apop-
tosis from oxidative stress in vitro. 
Summarizing the above mentioned facts, we conclude 
that mechanisms of beneficial effects of flavonoids in 
cardiovascular diseases are based mainly on their anti-
oxidant and antiinflammatory properties. On the other 
hand, the mechanism of cardiac hypethrophy prevention 
b y  fl a v o n o i d s  i s  s u g g e s t e d  t o  o p e r a t e  via protection 
against apoptotic cell death of cardiomyocytes.
Doxorubicin-induced cardiomyocyte injury
The effectiveness of the anticancer drug doxorubicin 
is severely limited by its cardiac side-effects related to 
cardiomyopathy and heart failure (Clement, 2009). The 
putative mechanism of doxorubicin-induced cardiotoxic-
ity is the generation of reactive oxygen species during its 
intracellular metabolism (Choi et al., 2007). An increas-
ing number of studies suggest that disruption of calcium 
(Ca2+) homeostasis is another important cause for doxo-
rubicin-mediated cardiotoxicity. Precise Ca2+ handling 
in cardiomyocytes is crucial for excitation–contraction 
coupling, the process that enables the heart to function 
effectively as a pump. Doxorubicin was reported to 
regulate the functions of L-type Ca2+ channels, Na+/Ca2+ 
exchanger, SERCA2 gene transcription and ryanodine 
receptors, thus modulating heart contractile function. 
(Zheng et al., 2011)
Doxorubicin-induced cardiac myopathy was found to 
be reduced by antioxidant properties of EGCG. (Bast et 
al., 2007). In addition, EGCG protection has also other 
aspects. One such aspect is its protein-binding ability 
which can help in the protection of cellular proteins 
against oxidative damage by reactive oxygen species 
(Hagerman  et al., 2003). As proteins are targets of 
oxidative damage, the interference of oxidative damage 
by EGCG may have a potential role in attenuating the 
development of cardiomyopathy. 
Oxidative stress may also influence Ca2+ homeo-
stasis by directly inducing mitochondrial permeability 
transition with modifications in mitochondrial calcium 
transport. The changes in calcium transport can further 
lead to tissue injury, cell killing and impaired cardiac 
contraction (Schimmel et al., 2004). EGCG significantly 
increased cell viability and protected against apoptosis in 
doxorubicin-treated cells.
The effect of EGCG on Ca2+ handling was studied in 
cardiac myocytes and it was found to protect myocytes 
against doxorubicin-induced intracellular calcium deple-
tion (Zheng et al., 2011).
In conclusion, EGCG-reduced cardiomyopathy after 
doxorubicin administration may be caused by several 
mechanisms: by antioxidant propeties of EGCG, its 
protein binding ability, protection against apoptosis of 
cardiac myocytes and protection against intracellular cal-
cium depletion. In this respect, SERCA may be involved 
in the above mentioned protection, as flavonoids are able 
to bind to SERCA, change its activity and thus also the 
intracellular calcium level.
SERCA dysfunction in diseases, posttranlational 
and conformational alterations
Conformational alterations of Ca2+-ATPases were stud-
ied in several diseases. Studies of ischemia/reperfusion 
in cardiac muscle and more recently in skeletal muscle 
showed that impaired sarcoplasmic reticulum (SR) func-
tion and Ca2+ homeostasis may be involved in the etiol-
ogy of ischemia/reperfusion injury. Ischemia–induced 
structural changes in SR Ca2+-ATPase are associated with 
reduced enzyme activity in rat muscle. Experiments with 
prolonged ischemia in rat skeletal muscle revealed that 
structural modifications to SR Ca2+-ATPase can explain 
the alterations in Ca2+-ATPase activity that occur with 
ischemia (Tuplin et al., 2001). They found that reduction 
in maximal SR Ca2+-ATPase activity in SR vesicles with 
ischemia was related to structural modification in the 
region of the nucleotide binding domain.
SERCA plays a key role in the relaxation of smooth, 
cardiac and skeletal muscle through the transport of 
cytosolic Ca2+ into SR or ER (MacLennan et al., 1997; 
East, 2000; Sharov et al., 2006). However also other physi-
ological and pathological processes are associated with an 
abnormal activity and expression of SERCA, such as cell 
proliferation, apoptosis, Brody and Darier disease and 
cancer (Sharov et al., 2006). 
By reacting with superoxide anion, the less reactive 
NO forms the more thiol reactive oxidant peroxynitrite, 
which in turn can adduct glutathione (GSH) to SERCA 
cysteine thiols. The reaction of NO with superoxide anion 
is required, as indicated by the fact that mouse arteries in 
which superoxide dismutase is overexpressed relax less to 
NO (Adachi et al., 2004). The majority of GSH on SERCA 
is bound to the most reactive thiol on cysteine-674, and 
mutation of this single cysteine prevents not only forma-
tion of most GSH adducts but also stimulation of Ca2+ 
uptake by NO. Tong et al. (2010) reported prevention of 
such stimulation of Ca2+ by Cys674 mutation associated 
with decrease of cell migration. NO function is impaired 
in a variety of cardiovascular diseases, including diabetic 
vascular disease and atherosclerosis, which are associated 
with irreversible oxidation of SERCA cysteine-674 (Tong 
et al., 2010).
In atherosclerotic arteries, NO can not stimulate 
SERCA activity because of the irreversible oxidation of the 
cysteine-674 thiol caused by the high levels of oxidants 
accompanying the disease (Adachi et al., 2004).
Viner et al. (1999a) reported inactivation of SERCA 
by higher , pathological levels of NO or peroxynitrite. 
Such inactivation can be physiologically detrimental as 
a reduced function of SERCA has been associated with 
changed cellular response to apoptotic stimuli and also 121
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with an increased risk for cancer (Vanoverberghe et al., 
2004).
The increase of RNS in vascular diseases (such as ath-
erosclerosis or diabetes) irreversibly oxidizes Cys674 or 
nitrate tyrosine residues at Tyr 296-Tyr297, which is asso-
ciated with loss of SERCA function (Adachi et al., 2010). 
Oxidative inactivation of target proteins for NO can be 
associated with the pathogenesis of cardiovascular dis-
eases. Oxidative inactivation of SERCA is also implicated 
in dysregulation of smooth muscle migration, promotion 
of platelet aggregation and impairment of cardiac func-
tion, which can be associated with restenosis, pathological 
angiogenesis, thrombosis, as well as heart failure. Specific 
irreversible oxidative modifications consisting of sulfo-
nylation at cysteine 674 and nitration at tyrosines 294/295 
were found also in myocyte contractile dysfunction in the 
mouse heart mediated by reactive oxygen species (Lancel 
et al., 2010). 
NO-induced vasodilatation is impaired in patients with 
a variety of cardiovascular diseases, including diabetes, 
hypercholesterolemia (HC) and atherosclerosis (Adachi et 
al., 2002, 2004; Williams et al., 1996). SERCA 1 activity 
was markedly decreased in HC, although SERCA 2 pro-
tein expression did not change (Adachi et al., 2001). The 
abnormal SERCA function in the HC rabbit aorta can be 
attributed to extensive oxidant-induced tyrosine nitration 
and thiol oxidation of SERCA (Adachi et al., 2002; Ying 
et al., 2008). Both tyrosine nitration and thiol oxidation 
may be attributed to excess production of peroxynitrite, 
the chemical product of NO and superoxide (Adachi et al., 
2002; Ying et al., 2008).
In diabetic and insulin-treated diabetic Wistar rats, 
correlation was found between increase in tyrosine nitra-
tion of aortic SERCA2b and impaired aortic relaxation 
to acetylcholine, characteristic for the diabetic state 
(Adachi et al., 2001). Prolonged treatment of the diabetic 
rat with insulin also impaired aortic relaxations that were 
attributed to dysfunction of the smooth muscle and were 
caused, at least in part, by SERCA dysfunction (Adachi 
et al., 2001). In the streptozotocin-induced diabetic rat 
model, increased plasma angiotensin II and peroxynitrite 
levels impaired cyclic GMP-independent aortic relaxation, 
apparently by inhibiting SERCA (Taguchi et al., 2007).
Additionally, the diabetic HC pig aorta contained 
SERCA2b in which the cysteine-674 thiol was oxidized, 
and this was prevented in pigs treated with insulin. 
Interestingly, the irreversible oxidation of SERCA in the 
diabetic pig aorta corresponded to a less intact 110 kDa 
SERCA protein and a lower molecular mass SERCA pro-
tein of approximately 70 kDa. These studies suggest that 
SERCA degradation is associated with its oxidation and 
may play a role in progression of diabetic vascular disease 
(Ying et al., 2008).
SERCA2 in platelets from patients with type 2 diabetes 
mellitus showed increased tyrosine nitration accompa-
nied by inactivation of SERCA, elevated platelet free Ca2+ 
levels, and activated μ-calpain. The tyrosine nitration of 
SERCA2 and the activation of μ-calpain in platelets from 
healthy volunteers could be evoked by peroxynitrite in 
vitro, implicating the importance of oxidation of SERCA 
in diabetic patients (Randriamboavonjy et al., 2008).
According to our recent results, development of adju-
vant arthritis in an animal model was related to modula-
tion of SERCA activity and correlated with oxidation of 
cysteine and nitration of tyrosine. We concluded that 
nitric oxide may regulate cytoplasmic Ca2+ level through 
conformational alterations in the transmembrane Ca2+ 
binding domain of SERCA (Strosova et al., 2011).
Biological aging leads to oxidation and nitration 
of SERCA at Cys and Tyr residues (Restall et al., 1986), 
accompanied by partial inactivation of SERCA activity 
and to a conformationally altered nucleotide binding 
site (Chen et al, 1999). Sharov et al. (2006) found that 
age-dependent loss of Cys residues may be partially 
responsible for the age-dependent decrease of the specific 
Ca-ATPase activity. Biological aging resulted in partial 
modification of Cys residues 377, 498, 525, 561, 614, 636, 
674, 675, 774, 938. In the SERCA2a from aged slow-twich 
skeletal muscle (Viner et al., 1999b) and heart (Knyushko 
et al., 2005) accumulation of 3-nitrotyrosine (3-NT) 
at positions 294, 295, located at the lumen-membrane 
interface of the transmembrane helix M4, and at position 
753 was found.
Summarizing SERCA dysfunction in the above 
mentionad diseases, it can be concluded that cysteine 
sulfhydryls, mainly in Cys 674 and tyrosine nitration 
usually at positions 294, 295, are the main posttransla-
tional alterations of SERCA responsible for modulation 
of its activity, correlating with pathological disorders. 
Conformational alterations of SERCA in cytosolic nucleo-
tide (ATP-binding) sites observed both in aging and in 
ischemia/reperfusion were found in cardiac and skeletal 
muscles, while conformational changes in the transmem-
brane domain of SERCA were associated with adjuvant 
arthritis. Several authors concluded that SERCA oxidative 
posttranslational modifications contributed to the patho-
physiology of individual diseases and that preservation of 
SERCA function and/or increasing expression of SERCA 
may be a novel strategy against diseases associated with 
oxidative stress (Adachi et al., 2010, Lancet et al., 2010, 
Tong et al., 2010, Inesi et al., 2005).
SERCA as a therapeutic target to prevent 
vascular disease development
Preventing SERCA oxidation and/or providing new 
SERCA protein may improve vascular disease develop-
ment as indicated by several examples. In a study of 
impaired endothelium-dependent relaxations in the HC 
rabbit aorta, the antioxidant t-butylhydroxytoluene (BHT) 
dramatically improved the smooth muscle response to 
NO. The beneficial effects of the antioxidant depended on 
improvement of the response to NO in the smooth muscle 
cells (SMC) (Adachi et al., 2002). BHT also restored the 
decreased aortic SERCA activity in HC and decreased 
tyrosine-nitrated SERCA without changing SERCA pro-
tein expression. These beneficial effects may depend on 122
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decreasing the direct effects of ROS/RNS on SERCA that 
are augmented in HC (Adachi et al., 2002).
Another example is improvement of endothelium-
dependent relaxation which precedes the regression of 
atherosclerosis caused by cholesterol lowering or antioxi-
dant treatments. This suggests that improvement of the 
response to NO can limit the progression of atherosclero-
sis. The improvement in SMC function is associated with 
decreased oxidative modification of SERCA protein and 
improved Ca2+ uptake activity. This suggests that preser-
vation of SERCA function may be regarded as a new target 
for the treatment of impaired vascular function.
In the streptozotocin-induced diabetic rat model, 
elevated plasma angiotensin II levels were improved 
by treatment with the angiotensin-converting enzyme 
inhibitor enalapril. As angiotensin II is a powerful inducer 
of NADPH oxidase, it is likely that enalapril helps prevent 
the diabetes-related impairment of SERCA function in the 
aorta by suppressing ROS formation (Taguchi et al. 2007).
The enhanced tyrosine nitration and inactivation of 
SERCA2 in platelets from type 2 diabetic patients were 
restored by treating the patients with rosiglitazone. This 
was accompanied by improvements in platelet [Ca2+]i and 
aggregation, indicating the importance of SERCA oxida-
tion in platelet function in diabetic patients. Rosiglitazone 
also partially restored inhibition of platelet aggregation 
by NO, consistent with improvements in SERCA redox 
function (Randriamboavonjy et al., 2008).
Nitrotyrosine, an indirect marker of peroxinitrite, 
was markedly increased in aortic smooth muscle from 
diabetic rats, while chronic enalapril administration 
reduced this increase. In streptozotocin-induced diabetic 
rats, angiotensin II production may lead to the generation 
of peroxynitrite and this may in turn trigger dysfunction 
of vascular smooth muscle SERCA (Taguchi et al., 2007).
NO relaxes arteries, in part by stimulating Ca2+ uptake 
via SERCA in aortic smooth muscle, while HC impairs 
SERCA function and the response to NO. HC induces 
oxidative stress, which can impair SERCA function. 
Antioxidant BHT reversed impaired smooth muscle 
SERCA function in HC, which correlated with improved 
relaxation to NO (Adachi et al., 2002). 
Conclusions
Both physiological and pathophysiological levels of ROS/
RNS regulate cell functions by direct modifications of 
SERCA. This may contribute to the understanding of the 
way in which ROS/RNS regulate cell function and may 
also suggest new strategies to prevent vascular diseases 
and development of cancer.
Flavonoids are able to initiate apoptosis, especially 
in cancer cells, via a Ca2+-dependent mitochondrial 
pathway, which can be activated through an exaggerated 
elevation of cytosolic [Ca2+]i and at least partially via sar-
coplasmic/endoplasmic reticulum Ca2+-ATPases. Thus 
flavonoids may be a useful tool for preventing cancer 
development. 
On the other hand, decrease of apoptosis is required 
in some cases. In cardiac hypertrophy in vitro and in vivo 
induced by ROS/RNS, the changes in calcium transport 
can further lead to tissue injury, cell killing and impaired 
cardiac contraction. Some flavonoids significantly 
increased cell viability and protected against cardiomyo-
cyte apoptosis, via preservation of SERCA function, which 
can be a novel strategy against cardiovascular diseases 
associated with oxidative stress.
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